{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:50:17Z","timestamp":1793364617151,"version":"4.5.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J App Basic Med Res"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/2229-516x.179027","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T00:09:49Z","timestamp":1458605389000},"page":"84","source":"Crossref","is-referenced-by-count":164,"title":["Human papillomavirus-associated cancers: A growing global problem"],"prefix":"10.4103","volume":"6","author":[{"given":"Bhavana","family":"Rai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshuma","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MiniP","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2229-516X.179027-1","first-page":"1969","volume-title":"EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease","author":"Arbyn","year":"2012","journal-title":"Int J Cancer"},{"key":"key-10.4103\/2229-516X.179027-2","first-page":"890","volume-title":"Human papillomavirus and cervical cancer","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"key-10.4103\/2229-516X.179027-3","first-page":"44","volume-title":"Sexually transmitted diseases of the vulva.Ridley's The Vulva, Third Edition","author":"Nwokolo","year":"2009","journal-title":""},{"key":"key-10.4103\/2229-516X.179027-4","first-page":"453","volume-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis","author":"de","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"key-10.4103\/2229-516X.179027-5","first-page":"1510","volume-title":"Involvement of intact HPV16 E6\/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control","author":"Wiest","year":"2002","journal-title":"Oncogene"},{"key":"key-10.4103\/2229-516X.179027-6","first-page":"2449","volume-title":"Identification of the alpha6 integrin as a candidate receptor for papillomaviruses","author":"Evander","year":"1997","journal-title":"J Virol"},{"key":"key-10.4103\/2229-516X.179027-7","first-page":"5810","volume-title":"The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes","author":"Joyce","year":"1999","journal-title":"J Biol Chem"},{"key":"key-10.4103\/2229-516X.179027-8","first-page":"S2","volume-title":"Reducing the economic burden of HPV-related diseases","author":"Mayeaux","year":"2008","journal-title":"J Am Osteopath Assoc"},{"key":"key-10.4103\/2229-516X.179027-9","first-page":"227","volume-title":"Oral squamous cell carcinoma; from an hypothesis about a virus, to concern about possible sexual transmission","author":"Scully","year":"2002","journal-title":"Oral Oncol"},{"key":"key-10.4103\/2229-516X.179027-10","first-page":"3122","volume-title":"Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test","author":"van","year":"2006","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/2229-516X.179027-11","first-page":"2674","volume-title":"Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix","author":"Khouadri","year":"2007","journal-title":"Int J Cancer"},{"key":"key-10.4103\/2229-516X.179027-12","first-page":"5088","volume-title":"Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy","author":"Kim","year":"2009","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/2229-516X.179027-13","first-page":"670","volume-title":"Prevalence of human papillomavirus infection in unselected SurePath samples using the APTIMA HPV mRNA assay","author":"Rebolj","year":"2013","journal-title":"J Mol Diagn"},{"key":"key-10.4103\/2229-516X.179027-14","first-page":"99","volume-title":"Cervista HPV HR test kit in cervical cancer screening","author":"Wiwanitkit","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"key-10.4103\/2229-516X.179027-15","first-page":"401","volume-title":"A comparison of two methods to determine the presence of high-risk HPV cervical infections","author":"Johnson","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"key-10.4103\/2229-516X.179027-16","first-page":"261","volume-title":"The clinical utility of HPV DNA testing in cervical cancer screening strategies","author":"Bhatla","year":"2009","journal-title":"Indian J Med Res","ISSN":"https:\/\/id.crossref.org\/issn\/0971-5916","issn-type":"print"},{"key":"key-10.4103\/2229-516X.179027-17","first-page":"61","volume-title":"Carcinoma cervix treated with radiotherapy \u2013 Our experience with emphasis on our concern","author":"Arulponni","year":"2010","journal-title":"J Obstet Gynecol India"},{"key":"key-10.4103\/2229-516X.179027-18","first-page":"219","volume-title":"The magnitude of cancer cervix in India","author":"Nandakumar","year":"2009","journal-title":"Indian J Med Res","ISSN":"https:\/\/id.crossref.org\/issn\/0971-5916","issn-type":"print"},{"key":"key-10.4103\/2229-516X.179027-19","first-page":"2599","volume-title":"A cross-sectional study of a prototype carcinogenic human papillomavirus E6\/E7 messenger RNA assay for detection of cervical precancer and cancer","author":"Castle","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key-10.4103\/2229-516X.179027-20","first-page":"940","volume-title":"Human papillomavirus testing methods","author":"Hubbard","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"key-10.4103\/2229-516X.179027-21","first-page":"1072","volume-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/2229-516X.179027-22","first-page":"396","volume-title":"Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: A longitudinal French cohort study","author":"Dalstein","year":"2003","journal-title":"Int J Cancer"},{"key":"key-10.4103\/2229-516X.179027-23","first-page":"2189","volume-title":"Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: A nested case-control study","author":"Josefsson","year":"2000","journal-title":"Lancet"},{"key":"key-10.4103\/2229-516X.179027-24","first-page":"451","volume-title":"Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection","author":"Lillo","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/2229-516X.179027-25","first-page":"270","volume-title":"Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions","author":"Monnier-Benoit","year":"2006","journal-title":"J Clin Virol"},{"key":"key-10.4103\/2229-516X.179027-26","first-page":"590","volume-title":"Human papillomavirus 16 load in normal and abnormal cervical scrapes: An indicator of CIN II\/III and viral clearance","author":"van","year":"2002","journal-title":"Int J Cancer"},{"key":"key-10.4103\/2229-516X.179027-27","unstructured":"Cuzick J. Viral load as surrogate for persistence in cervical human papillomavirus infection. In: Development in Cervical Cancer Screening and Prevention. Oxford: Blackwell; 1997. p. 372-8."},{"key":"key-10.4103\/2229-516X.179027-28","first-page":"886","volume-title":"Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique","author":"Peitsaro","year":"2002","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/2229-516X.179027-29","first-page":"3678","volume-title":"Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma","author":"Saunier","year":"2008","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/2229-516X.179027-30","first-page":"178","volume-title":"Prevalence of human papillomavirus in women without cervical cancer: A population-based study in Eastern India","author":"Dutta","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"key-10.4103\/2229-516X.179027-31","first-page":"131","volume-title":"Prognostic value of measuring load of human papillomavirus DNA in cervical samples: An elusive target","author":"Franco","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/2229-516X.179027-32","first-page":"160","volume-title":"The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China","author":"Wang","year":"2012","journal-title":"BMC Cancer"},{"key":"key-10.4103\/2229-516X.179027-33","first-page":"2869","volume-title":"Situation of HPV16 E2 gene status during radiotherapy treatment of cervical carcinoma","author":"Kahla","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"key-10.4103\/2229-516X.179027-34","first-page":"663","volume-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: A population-based study in routine clinical practice","author":"Katki","year":"2011","journal-title":"Lancet Oncol"},{"key":"key-10.4103\/2229-516X.179027-35","first-page":"744","volume-title":"Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity","author":"Gillison","year":"2004","journal-title":"Semin Oncol"},{"key":"key-10.4103\/2229-516X.179027-36","first-page":"3036","volume-title":"HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women","author":"Gillison","year":"2008","journal-title":"Cancer"},{"key":"key-10.4103\/2229-516X.179027-37","first-page":"S5","volume-title":"The role of HPV in head and neck cancer and review of the HPV vaccine","author":"D'Souza","year":"2011","journal-title":"Prev Med"},{"key":"key-10.4103\/2229-516X.179027-38","first-page":"1510","volume-title":"Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy","author":"Hong","year":"2010","journal-title":"Br J Cancer"},{"key":"key-10.4103\/2229-516X.179027-39","first-page":"29S","volume-title":"Human papillomavirus (HPV)-associated oral cancers and treatment strategies","author":"Sathish","year":"2014","journal-title":"J Dent Res"},{"key":"key-10.4103\/2229-516X.179027-40","first-page":"1494","volume-title":"Treatment de-escalation in HPV-positive oropharyngeal carcinoma: Ongoing trials, critical issues and perspectives","author":"Mirghani","year":"2015","journal-title":"Int J Cancer"},{"key":"key-10.4103\/2229-516X.179027-41","first-page":"398","volume-title":"HPV infection, anal intra-epithelial neoplasia (AIN) and anal cancer: Current issues","author":"Stanley","year":"2012","journal-title":"BMC Cancer"},{"key":"key-10.4103\/2229-516X.179027-42","first-page":"645","volume-title":"Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence.A systematic review of 3322 published patients?","author":"van","year":"2005","journal-title":"Gynecol Oncol"},{"key":"key-10.4103\/2229-516X.179027-43","first-page":"1928","volume-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2229-516X.179027-44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000357907","volume-title":"Human papillomavirus and immunosuppression","author":"Wieland","year":"2014","journal-title":"Curr Probl Dermatol"},{"key":"key-10.4103\/2229-516X.179027-45","first-page":"58","volume-title":"Host responses to infection with human papillomavirus","author":"Stanley","year":"2014","journal-title":"Curr Probl Dermatol"},{"key":"key-10.4103\/2229-516X.179027-46","first-page":"217","volume-title":"Prophylaxis of cervical cancer and related cervical disease: A review of the cost-effectiveness of vaccination against oncogenic HPV types","author":"Armstrong","year":"2010","journal-title":"J Manag Care Pharm"},{"key":"key-10.4103\/2229-516X.179027-47","first-page":"457","volume-title":"Current prophylactic HPV vaccines and gynecologic premalignancies","author":"Harper","year":"2009","journal-title":"Curr Opin Obstet Gynecol"},{"key":"key-10.4103\/2229-516X.179027-48","first-page":"c3493","volume-title":"Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: Randomised controlled trial","author":"FUTURE","year":"2010","journal-title":"BMJ"},{"key":"key-10.4103\/2229-516X.179027-49","first-page":"301","volume-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"key":"key-10.4103\/2229-516X.179027-50","first-page":"408","volume-title":"Prevention of persistent human papillomavirus infection by an HPV16\/18 vaccine: A community-based randomized clinical trial in Guanacaste, Costa Rica","author":"Herrero","year":"2011","journal-title":"Cancer Discov"},{"key":"key-10.4103\/2229-516X.179027-51","first-page":"394595","volume-title":"HPV vaccination in India: Critical appraisal","author":"Nigam","year":"2014","journal-title":"ISRN Obstet Gynecol"},{"key":"key-10.4103\/2229-516X.179027-52","first-page":"69","volume-title":"Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems","author":"Tahamtan","year":"2014","journal-title":"J Biomed Sci"}],"container-title":["International Journal of Applied and Basic Medical Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:25:50Z","timestamp":1786713950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/2229-516X.179027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"alternative-id":["179027"],"URL":"https:\/\/doi.org\/10.4103\/2229-516x.179027","relation":{},"ISSN":["2229-516X"],"issn-type":[{"value":"2229-516X","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}